WORKPLACE SUBSTANCE USE, THE RISK OF OCCUPATIONAL INJURY, AND TESTING [PDF]
, 2005 Over the past 20 years, the "workplace substance abuse prevention industry" has grown enormously in size and has become more sophisticated in its marketing approach. Drug testing alone has become a $6 billion industry.
Zimbardi, Guy
core
Metabolic Profiling and Investigation of the Modulatory Effect of Fagonia cretica L. Aerial Parts on Hepatic CYP3A4 and UGT2B7 Enzymes in Streptozotocin-Induced Diabetic Model. [PDF]
Antioxidants (Basel), 2023 Kamran S +6 more
europepmc +1 more source
Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids. [PDF]
ACS Sustain Chem Eng, 2021 Jia X +5 more
europepmc +1 more source
Deconstructing Drugs: Addressing the Stigma, Harm Reduction, and Policy Solutions [PDF]
Black and homeless people who struggle with substance use disorder (SUD), especially opioid use disorder (OUD), have experienced unique obstacles due to inequalities relating to their social determinants of health (SDOH).
Theriault, Charlotte
core +1 more source
EFFECT OF NALORPHINE ON THE RELEASE OF PITUITARY GONADOTROPHINS IN MALE RATS [PDF]
, 1967 Shri N. Giri
openalex +1 more source
Role of the gut-brain axis in HIV and drug abuse-mediated neuroinflammation. [PDF]
Adv Drug Alcohol Res, 2023 Ray S +4 more
europepmc +1 more source
Analgesia in pancreatitis with special reference to the effect on pressure in the common bile-duct [PDF]
, 2018 No ...
Efron, G.
core +1 more source
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients. [PDF]
Transl Psychiatry, 2022 Shang P +18 more
europepmc +1 more source
The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects [PDF]
, 1969 Francis F. Foldes +2 more
openalex +1 more source